BOYDSenseBOYDSense SAS

BOYDSenseBOYDSense SAS

Signal active

Organization

Contact Information

Overview

BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronic diseases.

It was founded in 2015 and headquartered in South San Francisco, California.

About

Industries

Health Care, Medical Device, Health Diagnostics

Founded

2015

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

BOYDSenseBOYDSense SAS headquartered in United States, North America, operates in the Health Care, Medical Device, Health Diagnostics sector. The company focuses on Health Care and has secured $249.9M in funding across 24 round(s). With a team of 1-10 employees, BOYDSenseBOYDSense SAS is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - BOYDSenseBOYDSense SAS, raised $7.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Arnaud Debains

Arnaud Debains

Managing Director

imagePlace Bruno Thuillier

Bruno Thuillier

Founder, CTO, and CEO

imagePlace Sandrine Isz

Sandrine Isz

CSO

Funding Rounds

Funding rounds

2

Investors

7

Lead Investors

0

Total Funding Amount

$10.4M

Details

0

BOYDSenseBOYDSense SAS has raised a total of $10.4M in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

BOYDSenseBOYDSense SAS is funded by 11 investors.

Investor NameLead InvestorFunding RoundPartners
Swiss Diabetes Venture Fund-FUNDING ROUND - Swiss Diabetes Venture Fund7.6M
Alpha MOS-FUNDING ROUND - Alpha MOS7.6M
BOYDSenseBOYDSense SAS-FUNDING ROUND - BOYDSenseBOYDSense SAS7.6M
Sweet Ventures-FUNDING ROUND - Sweet Ventures7.6M

Recent Activity

There is no recent news or activity for this profile.